0920_Complete_Digital_Edition

PM36OThe Essential Resource for Pharma Marketerswww.PM360online.comsePteMber 2020Join Us For the trailblazer awards event!october 1 @ 6PM(see back cover)covid-19’s impact on Patient engagement improving health literacy to reach all / Patients solving Financial toxicity due to increased Unemployment best ways to //Get new Patients started on the right FootIn this issueN E W W O R L D ,N E W P A T IE N TE X P E R IE N C E



Publisher’s Messagehttp://linkd.in/PM360Groupwww.facebook.com/PM360magazinewww.twitter.com/PM360onlineRedefining the Patient Experience Cover Art:shutterstock.com•special issue: 2020 Trailblazer awards winners• staying ahead of theimmersions Game—new waysto Tap into ar, Vr, Mr• How rwe is reshaping clinical Trials• capitalizing on the rise ofdigital Therapeutics Focus on: new Med TechInOctoberOne phrase that has almost been inescapable as we all learn to adjust to the pandemic is “the new normal.” People are encouraged to wear masks wherever they go, wash their hands regularly and thoroughly, avoid contact with people and things, and so much more. But while some of these things may just be minor inconveniences to many of us, perhaps no one has seen their lives more upended than patients. This impact goes beyond high-risk patients—the entire patient experience has been forced to rapidly evolve. A July 2020 report from the U.S. Department of Health and Human Services found that telehealth adoption increased by nearly 50% in primary care at the peak of the pandemic. But virtual doctor visits are not the only change. More patients are getting medications delivered to their home. Clinical trials are using more wearables and smart devices to monitor participants remotely. Even office visits are different with more contactless displays offering patient education by allowing people to scan a code so they can view the information on their phone.This is the new normal for patients. Many expect these changes and more to remain long past the current pandemic. That means our industry will also need to adjust to how it serves patients and offer new ways to improve their experience. The good news—it is clear we are up for the challenge. In this issue alone, you will find insights on how companies can improve healthcare literacy and deliver more easily understandable information (especially regarding vaccines, which will hopefully be very important in the near future); ways to ease the burden of financial toxicity and aid patients who now find themselves uninsured; advice on the best tools and services to offer newly diagnosed patients; and more of the ways COVID-19 will change the patient experience moving forward. Time and again we have seen our industry’s ability to deliver innovations to better serve patients. Heck, you don’t need to look any further than our recently announced Trailblazer Awards finalists to find a plethora of examples that demonstrate our industry’s unmatched imagination, ingenuity, and above all else, compassion for patients. That’s why we can’t wait to celebrate all of your achievements with our Trailblazer Awards Virtual Event on Thursday, October 1 at 6 PM EST. We promise you—this will be the event of the year. So, don’t miss it! Enjoy!Anna StashowerCEO/Publisher/Editor-in-ChiefPM360 [email protected] EXPERT on CallHcp insiGHTsadrienne stevens, [email protected] 22daTa & analyTics sarah [email protected] 24auTHenTic paTienT Voice philip [email protected] 26 email the questions that are keeping you up at night to pM360’s September 2020 pm360 magazine /1PM 360Trailblazer Awards Virtual Event – Oct. 1 at 6 PM ESTWe are once again partnering with The Inception Company and their innovative Pando platform to deliver a unique virtual experience. Not only will we announce the winners live, but we will also interact with them on Pando’s 40-foot screen. And, of course, we will close out the event with a virtual dance party! Buy tickets at: www.pm360online.com/trailblazer-info. subMiT For THe innoVaTions issueFinal deadline is oct. 14as always, our December issue will feature the year’s most innovative Companies, startups, Divisions, Products, services, and strategies. and we know you have been especially innovative this year due to the pandemic, so we can’t wait to see what you’ve done. submit at: www.pm360online.com/innovations-issue.www.instagram.com/pM360magazine

Carmine AttanasioAssociate Director, Digital Product MarketingHematology—Multiple MyelomaBristol Myers SquibbSummit, NJJulie BakerVice President, MarketingGreenwich BiosciencesCarlsbad, CARich BaronExecutive Director, Prescription Medicine Training & DevelopmentBoehringer Ingelheim Ridgefield, CTBud Bilanich, EdDThe Common Sense GuyFaculty Member Daniels College of BusinessUniversity of DenverDenver, CORobert CecereChief Growth OfficerData360Princeton, NJLinda CherryHead of Commercial OncologyRadius HealthWayne, PADavid DavidovicPresidentpathForwardSan Francisco, CABunny EllerinDirector, Healthcare & Pharmaceutical Management ProgramColumbia Business SchoolNew York, NYJenn EtheridgeSenior Marketing ManagerGenentechSouth San Francisco, CAKendra FanaraGeneral Manager, NeurologySunovionMarlborough, MALisa FlaizDirector, U.S. Consumer Digital HubBristol Myers SquibbLawrenceville, NJ Debra HaganExecutive Director, CNS MarketingAbbVieMadison, NJ Jim LefevereInternational Business Leader, Non-Insulin Therapy Solutions Strategy & Customer SolutionsRoche Diabetes Care, Inc.Indianapolis, INSimon CS LemmyHead of Rheumatology, Sales and Marketing UCBAtlanta, GAKayte LockDirector, U.S. Oncology National Customer Group Pfizer New York, NYMike MarettFounder & CEO Confideo New York, NYLars Merk Marketing Director AstraZenecaFort Washington, PADavid MooreVant CEORoivant Family of Companies Cary, NC Mario R. Nacinovich, Jr.Vice President, MarketingEyevance Pharmaceuticals, LLCFort Worth, TXMichael NesrallahVice President, Franchise Head, Inflammatory Bowel DiseaseGastroenterology Business UnitTakeda Pharmaceuticals USADeerfield, ILBrian PetersVP, Sales & MarketingMedexus PharmaChicago, ILFrank X. PowersManaging PartnerElevate HealthcareBlue Bell, PAMike RivasGlobal Head, Ethics and Compliance, Cell & Gene TherapiesNovartis Pharmaceuticals CorporationEast Hanover, NJRamiro RomanDivisional Vice President and General Manager Abbott Lake Forest, ILSandy SextonSenior Director, MarketingRegeneronTarrytown, NYDora P. ShankmanPresident and CEOShankman Marketing and Media ResourcesLong Valley, NJJim SluckVP Dry Eye MarketingSight SciencesFort Worth, TXSantos Torres, Jr. U.S. PharmaceuticalsSenior Director of Marketing, Allergy/Anti-Infectives/Anti-ViralsBausch + Lomb Bridgewater, NJJohn M. VieiraU.S. Head of CommercializationSol-GelCedar Knolls, NJAndrew J. WatsonSenior Director, MarketingAmarin Pharma Inc. Bedminster, NJMoriah J. Weissman, PharmD, CCPStrategy and Communications Director - Benign Heme/Sickle Cell Disease, Novartis Pharmaceuticals Corp.San Diego, CACorbin WoodChief Operating OfficerSnow CompaniesWilliamsburg, VA2020Editorial advisory board2 pm360 magazine September 2020/